-
Beaumont Doctor One of First to Use New Prostate Treatment
21 Oct 2021 18:11 GMT
… a temporary implant treatment device called iTind used to treat benign prostatic hyperplasia (BPH).
Scott Callison … device is an alternative to medications, surgery, and permanent implants. Also …
-
US FDA grants breakthrough device designation to Varian's Embozene microspheres for GAE for symptomatic knee osteoarthritis
16 Oct 2021 07:41 GMT
… Food and Drug Administration (FDA) has granted … uterine fibroids and benign prostatic hyperplasia.
Embozene microspheres received … Treatment for osteoarthritis often escalates from over-the-counter medications … help accelerate the development, assessment and …
-
Peritoneal Dialysis Market Rising Prevalence of ESRD & Demand for Home Dialysis Treatment Drive the Market Growth
13 Oct 2021 11:59 GMT
… such as needle free treatment, portability, treatment convenience, and less … about advanced APD technique, developed healthcare infrastructure, and rise … Request for 14 days free trial: https:// … Research By 2030
Laser BPH Devices Market Global …
-
Patient decision aids in urology don't meet quality and readability standards
19 Oct 2021 01:00 GMT
… conditions commonly treated by urologists: benign prostatic hyperplasia (enlarged prostate), overactive bladder, … quality of the information regarding treatment choices.
Minimum standards: An … researchers identify some steps developers can follow to improve …
-
Urinalysis Market Size ($5,937.97Mn by 2028) Lead by Sediment Urinalysis Test (5.6% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
21 Oct 2021 15:03 GMT
… developments in urinalysis market; and developments in … . Ulcerative Colitis Treatment Market Forecast to … and Fulminant Colitis); Medication (5-Aminosalicylates, Steroids … (Hospitals Pharmacies, Pharmacies & Drug Stores, and Online Pharmacies), End …
-
Plant Sterol Esters Market Size Forecast to Grow at a CAGR of 6.5% During 2021-2026
20 Oct 2021 01:00 GMT
… the treatment of an enlarged prostate (Benign Prostatic Hyperplasia or BPH). The … market. Furthermore, the development of biotechnology and … their budgets on treating health conditions especially …
US Food and Drug Administration (FDA) classifies plant sterol …
-
Patient decision aids for urologic conditions fall short of quality and readability standards
19 Oct 2021 07:07 GMT
… for treatment. Our study highlights the need to develop urologic … conditions commonly treated by urologists: benign prostatic hyperplasia (enlarged prostate), overactive bladder, … quality of the information regarding treatment choices.
Minimum standards: An …
-
Medical Laser Market by regional growth, trend and industry outlook 2021-2025
19 Oct 2021 05:41 GMT
… field have improved the treatment procedure of benign prostatic hyperplasia (BPH) and lithotripsy, and … awareness regarding novel clinical treatments could stimulate regional market growth … They are also focusing on developing innovative solutions to gain a …
-
Global Next-Generation Sequencing (NGS) Market Share, Size, Growth, Industry Report, Trends and Opportunities 2021-26
19 Oct 2021 04:28 GMT
… by Application:
Drug Discovery and … Benign Prostatic Hyperplasia Treatment Market: https://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment … developments for business leaders in biotechnology, advanced materials, pharmaceuticals …
-
Profound Medical to Release Third Quarter 2021 Financial Results on November 4 Conference Call to Follow
18 Oct 2021 23:45 GMT
… medical device company that develops and markets customizable, … zone in large volume benign prostatic hyperplasia (BPH). TULSA-PRO® is … .S. Food and Drug Administration (“FDA”). Profound is also … -invasive treatment of uterine fibroids and has FDA approval …
About
© 1995-2021